Downloads

Get access to downloadable PDFs of our reports, graphics and breakdowns for free

Well, almost free. Enter and verify your email below for access (no spam, only great content, we promise)

In-Vivo-Cell-Therapy-Landscape-Oct25.pdf277.04 KB
Deal-Thermometer-Across-TAs-Sleuth-Sep25.pdf217.59 KB
T12-Oncology-focused-Pharma-are-increasingly-modality-agnostic-Sleuth-Aug25.pdf294.09 KB
Obesity-Portfolio-Gaps-in-Big-Pharma-Sleuth-Aug25.pdf233.27 KB
YTD-2025-China-Out-Licensing-Deals-Jul25.pdf871.40 KB
Sleuth-COPD-Cytokine-Chessboard-Jul25-1.pdf256.13 KB
Landscape-of-Orexin-targeting-drugs-Jul25.pdf122.95 KB
Landscape-of-OXR2-targeting-drugs-attacking-narcolepsy-Jul25.pdf184.44 KB
RNAi-Drugs-Pursuing-Obesity-Landscape-Jun25.pdf260.89 KB
PD-L1-x-VEGF-Competitive-Landscape-Mar25.pdf320.33 KB
Molecular-Glue-BD-Landscape-Since-2020-Mar25.pdf314.19 KB
YTD-2025-China-Out-Licensing-Deals-Feb25.pdf433.79 KB
PD-L1xVEGF-Market-Overview-Feb25.pdf1,018.03 KB
Illustrative-duopolies-across-biopharma-landscape-Jan25.pdf820.27 KB
Eli-Lilly-Tirzepatide-Opportunity-Jan25.pdf1.19 MB
Novel-FDA-Drug-Approvals-Dec24.pdf1.21 MB
Potential-List-of-Drugs-Selected-for-IRA-Negotiation-in-2027-Nov24.pdf370.66 KB
MA-Deals-by-Big-Pharma-2019-2024-YTD-Nov24-1.pdf213.24 KB
Indication-Selection-Cheat-Sheet-Beware-Payor-Managed-Indications.pdf89.42 KB
Radiopharma-Isotope-Supplier-Market-Map-Oct24.pdf725.20 KB
Radiopharma-Portfolio-Gap-in-Big-Pharma-Oct24.pdf231.31 KB
Targeted-Therapy-Oncology-Landscape-Oct24.pdf301.30 KB
ADC_MA-and-IPO-Landscape-Sep24.pdf1.55 MB
Notable-Single-Asset-MA-Deals-2016-2019-Sep24.pdf1.42 MB
Indication-Intensity-Oncology-Aug24.pdf117.57 KB
Gene-Therapy-Landscape-Aug24.pptx.pdf137.61 KB
IRA-Price-Discount-Results-Aug24.pdf292.96 KB
Tech-Bio-Public-Stock-Performance-Aug24.pdf131.69 KB
FDA-Novel-Drug-Approvals-YTD-Aug24.pdf258.59 KB
Cell-Therapy-MA-and-IPO-Activity-Aug24.pdf1.03 MB
ADC-Market-Map_vF-Aug24.pdf655.93 KB
Largest-LOEs-and-Company-Valuation-Performance_vF-Jul24.pdf166.86 KB
FDA-Approved-CAR-T-Cell-Therapy-Sales-Over-Time-Jul24.pdf85.25 KB
Pancreatic-Cancer-Treatment-Landscape_vF-Jul24.pdf370.33 KB
ADC-Portfolio-Gap-in-Big-Pharma_vF-Jul24.pdf163.38 KB
Cell-Therapy-Supply-Chain-Market-Map_vFF-Jul24.pdf853.13 KB
5-Year-Survival-vs.-Incidence_vFF-Jun24.pdf58.79 KB
Autoimmune-Cell-Therapy-Landscape-June-2024_vFF-Jun24.pdf259.48 KB
FDA-Shortages-by-Year_vFF-May24.pdf50.37 KB
Biotech-Math-for-Dummies-Pharma-Edition_vFF-Feb24.pdf165.41 KB
CDk46-inhibitor-market-sales-and-forecast_vFF-Jan24.pdf122.45 KB
Cell-Therapy-MA-and-IPO-Activity_vFF-Jan24.pdf981.76 KB
mER-Breast-Cancer-Treatment-Landscape_vFF-Jan24.pdf285.61 KB
Projected-vs.-Actual-Performance-of-Select-New-Drugs_vFF-Nov23.pdf220.92 KB
ADC-Competitive-Landscape_vFF-Nov23.pdf208.52 KB
Notable-US-LOEs-by-Year-to-2028_vF-Oct23.pdf340.68 KB
Neuropsychiatric-Unmet-Need_vF-Oct23.pdf118.17 KB
Psychedelic-Primer-Market-Map_vF-Oct23.pdf465.17 KB
Select-Big-Pharma-AI-Partnerships_vF-Oct23.pdf608.97 KB
Neuropsychiatric-Competitive-Landscape_vF-Oct23.pdf318.05 KB
Notable-US-LOEs-by-Year-to-2028-Updated-Oct23.pdf310.84 KB
Cell-Therapy-MA-and-IPO-Activity-Sep23_vF.pdf732.02 KB
Keytruda-Graphics_vF-Sep23.pdf448.25 KB
Medicare-Spending-by-Top-Drugs_vF-Sep23.pdf478.40 KB
MA-Trend-Analysis-Sep23_vF-Sep23.pdf478.15 KB
Top-5-Assets-Organic-vs.-Acquired-for-Big-Pharma_vF-Aug23-1.pdf226.85 KB
Obesity-On-Ramp-Market-Map_vF-Aug23.pdf419.92 KB
Obesity-Market-Landscape-Updated-Aug23.pdf595.34 KB
EGFRm-Positive-NSCLC-Treatment-Landscape.pdf238.99 KB
Neuro-Oncology-Treatment-Landscape-Jul23.pdf383.36 KB
Radiotherapeutics-Market-Map_vF-Jun23.pdf860.86 KB
Gene-Editing-Competitive-Landscape_vF-Jun23.pdf563.57 KB
Asthma-and-COPD-Competitive-Landscape_vF-May23.pdf544.31 KB
Tech-Bio-Public-Stock-Performance_vF-Apr23.pdf267.21 KB
Cell-Therapy-Supply-Chain-Market-Map_vF-Apr23.pdf572.18 KB
RNA-Therapeutic-Market-Map_vF-Mar23.pdf2.05 MB
RNA-Therapeutics-Other_vF-Mar23.pdf2.24 MB
Alzheimers-Competitive-Landscape_vF-Mar23.pdf92.54 KB
Alzheimers-Market-Map-Other-Graphics_vF-Mar23.pdf561.83 KB
Psychedelic-Primer-Competitive-Landscape_vF-Feb23.pdf130.02 KB
Gene-Therapy-Landscape-Feb23_vF-Feb23.pdf136.76 KB
Notable-LOEs-by-Year-to-2028_vF-Jan23.pdf262.75 KB
Best-MA-Deals-Report_vF-Jan23.pdf177.06 KB
Cell-Therapy-Market-Map_vF-Jan23.pdf571.55 KB
DMD-Competitive-Landscape_vF-Jan23.pdf244.67 KB
High-Profile-Drug-Launches-in-2023_vF-Jan23.pdf150.76 KB
Obesity-Market-Competitive-Landscape_vF-Dec22.pdf215.29 KB
Cell-Therapy-Landscape-Dec22.pdf148.05 KB
Cell-Therapy-MA-and-IPO-Activity_vF-Dec22.pdf1.08 MB